IMMUNI T was launched in 2006 with a very simple goal: to carry out research and development protocols in support of discovery, pre-clinical and clinical efforts of biotech and pharmaceutical companies. Our team of expert researchers have successfully enhanced our clients’ resources for pre-clinical and clinical projects over the last 20 years. We have been and are still selected, sometimes for several years in a row, by big pharmaceutical companies around the world to perform their studies.

 

We are always in movement, and today, we operate a certified, state-of-the-art facility in the heart of Montreal and offer the full range of immunological services to complement the drug development process from discovery to post-market evaluations. IMMUNI T has developed an extensive network with the academic and biotech community and benefits locally from partnering resources with four Universities comprising Concordia University, McGill University, Université de Montréal, Université du Québec à Montréal and all major University hospitals in the city. We have developed significant expertise through experience in performing both standard and custom immuno-detection/diagnostic assays and assay validation. Our highly qualified scientific team, with an average of 20 years experience at supporting many biotech and pharmaceutical companies around the world, including Australia, Canada, China, Europe, India and USA.